Next Article in Journal
Fibrinogen as a Pleiotropic Protein Causing Human Diseases: The Mutational Burden of Aα, Bβ, and γ Chains
Next Article in Special Issue
Chaperones and the Proteasome System: Regulating the Construction and Demolition of Striated Muscle
Previous Article in Journal
Essential Oils from Neotropical Piper Species and Their Biological Activities
Previous Article in Special Issue
RNA Chaperone Function of a Universal Stress Protein in Arabidopsis Confers Enhanced Cold Stress Tolerance in Plants
Article Menu
Issue 12 (December) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2017, 18(12), 2709; https://doi.org/10.3390/ijms18122709

Heat Shock Proteins in Vascular Diabetic Complications: Review and Future Perspective

1
Laboratory of Diabetic Nephropathy, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy
2
Department of Clinical and Biological Sciences, University of Turin, Corso Raffaello 30, 10125 Turin, Italy
These authors contribute equally to this work.
*
Author to whom correspondence should be addressed.
Received: 27 November 2017 / Revised: 9 December 2017 / Accepted: 11 December 2017 / Published: 14 December 2017
(This article belongs to the Special Issue Molecular Chaperones)
View Full-Text   |   Download PDF [1846 KB, uploaded 14 December 2017]   |  

Abstract

Heat shock proteins (HSPs) are a large family of proteins highly conserved throughout evolution because of their unique cytoprotective properties. Besides assisting protein refolding and regulating proteostasis under stressful conditions, HSPs also play an important role in protecting cells from oxidative stress, inflammation, and apoptosis. Therefore, HSPs are crucial in counteracting the deleterious effects of hyperglycemia in target organs of diabetes vascular complications. Changes in HSP expression have been demonstrated in diabetic complications and functionally related to hyperglycemia-induced cell injury. Moreover, associations between diabetic complications and altered circulating levels of both HSPs and anti-HSPs have been shown in clinical studies. HSPs thus represent an exciting therapeutic opportunity and might also be valuable as clinical biomarkers. However, this field of research is still in its infancy and further studies in both experimental diabetes and humans are required to gain a full understanding of HSP relevance. In this review, we summarize current knowledge and discuss future perspective. View Full-Text
Keywords: diabetes; diabetes complications; diabetic retinopathy; diabetic nephropathy; diabetic retinopathy; diabetic neuropathy; heat shock proteins; Heat shock protein (HSP) 27; HSP47; HSP60; HSP70; HSP90; biomarkers; albuminuria diabetes; diabetes complications; diabetic retinopathy; diabetic nephropathy; diabetic retinopathy; diabetic neuropathy; heat shock proteins; Heat shock protein (HSP) 27; HSP47; HSP60; HSP70; HSP90; biomarkers; albuminuria
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Bellini, S.; Barutta, F.; Mastrocola, R.; Imperatore, L.; Bruno, G.; Gruden, G. Heat Shock Proteins in Vascular Diabetic Complications: Review and Future Perspective. Int. J. Mol. Sci. 2017, 18, 2709.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top